2:1 allocation [General Sta­tis­tics]

posted by msmnainar – India, 2021-06-23 18:49 (1478 d 00:52 ago) – Posting: # 22428
Views: 3,301

Hi Helmut,

Thanks for your detailed explanation.

❝ ❝ Note: The 2:1 randomization is mainly due to transition arm.


❝ What do you mean by that?


Transition arm is in general re-randomization at certain week after efficacy evaluation (FDA requirement).

Basically, 1:1 randomization allocation would lead to a larger sample size for subjects transitioning from Reference to Test, which would allow for detecting differences in immunogenicity and safety.

Sundar. M

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,679 registered users;
40 visitors (2 registered, 38 guests [including 10 identified bots]).
Forum time: 19:42 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5